3,4-dihydroxyphenylacetic acid has been researched along with HIV in 1 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scheller, C | 1 |
Arendt, G | 1 |
Nolting, T | 1 |
Antke, C | 1 |
Sopper, S | 1 |
Maschke, M | 1 |
Obermann, M | 1 |
Angerer, A | 1 |
Husstedt, IW | 1 |
Meisner, F | 1 |
Neuen-Jacob, E | 1 |
Müller, HW | 1 |
Carey, P | 1 |
Ter Meulen, V | 1 |
Riederer, P | 1 |
Koutsilieri, E | 1 |
1 other study available for 3,4-dihydroxyphenylacetic acid and HIV
Article | Year |
---|---|
Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Benzamides; Case-Control Studies; CD4 Antigens; Chemokine CCL | 2010 |